메뉴 건너뛰기




Volumn 19, Issue 5, 2009, Pages 488-492

Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population

(27)  Iwamoto, Naoki a   Kawakami, Atsushi a   Fujikawa, Keita a   Aramaki, Toshiyuki a   Kawashiri, Shin Ya a   Tamai, Mami a   Arima, Kazuhiko a   Ichinose, Kunihiro a   Kamachi, Makoto a   Yamasaki, Satoshi a   Nakamura, Hideki a   Nakashima, Munetoshi b   Mizokami, Akinari c   Goto, Akiko d   Fukuda, Takaaki d   Matsuoka, Naoki e   Ueki, Yukitaka f   Tsukada, Toshiaki g   Migita, Kiyoshi h   Shoumura, Fumiko i   more..


Author keywords

DAS28 ESR; Etanercept; MTX; Non MTX nonbiologic DMARDs; Rheumatoid arthritis

Indexed keywords

ACTARIT; BUCILLAMINE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; LEFLUNOMIDE; METHOTREXATE; MIZORIBINE; PENICILLAMINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TACROLIMUS; TIOPRONIN;

EID: 70350009796     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0187-8     Document Type: Article
Times cited : (26)

References (8)
  • 2
    • 0033611472 scopus 로고    scopus 로고
    • A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
    • Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 1999;340:253-9.
    • (1999) N Engl J Med , vol.340 , pp. 253-259
    • Weinblatt, M.E.1    Kremer, J.M.2    Bankhurst, A.D.3    Bulpitt, K.J.4    Fleischmann, R.M.5    Fox, R.I.6
  • 3
    • 37149038223 scopus 로고    scopus 로고
    • Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis
    • van der Heijde D, Klareskog L, Landewé R, Bruyn GA, Cantagrel A, Durez P, et al. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 2007;56:3928-39.
    • (2007) Arthritis Rheum , vol.56 , pp. 3928-3939
    • van der Heijde, D.1    Klareskog, L.2    Landewé, R.3    Bruyn, G.A.4    Cantagrel, A.5    Durez, P.6
  • 4
    • 0023945481 scopus 로고
    • The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
    • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24.
    • (1988) Arthritis Rheum , vol.31 , pp. 315-324
    • Arnett, F.C.1    Edworthy, S.M.2    Bloch, D.A.3    McShane, D.J.4    Fries, J.F.5    Cooper, N.S.6
  • 5
    • 33745037669 scopus 로고    scopus 로고
    • British Society for Rheumatology Biologics Register. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register
    • Hyrich KL, Watson KD, Silman AJ, Symmons DP. British Society for Rheumatology Biologics Register. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 2006;54:1786-94.
    • (2006) Arthritis Rheum , vol.54 , pp. 1786-1794
    • Hyrich, K.L.1    Watson, K.D.2    Silman, A.J.3    Symmons, D.P.4
  • 6
    • 43049169008 scopus 로고    scopus 로고
    • Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: Results from the South Swedish Arthritis Treatment Group Register
    • Kristensen LE, Kapetanovic MC, Gülfe A, Söderlin M, Saxne T, Geborek P. Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: Results from the South Swedish Arthritis Treatment Group Register. Rheumatology. 2008;47:495-9.
    • (2008) Rheumatology , vol.47 , pp. 495-499
    • Kristensen, L.E.1    Kapetanovic, M.C.2    Gülfe, A.3    Söderlin, M.4    Saxne, T.5    Geborek, P.6
  • 7
    • 0029911110 scopus 로고    scopus 로고
    • Low-dose corticosteroids in rheumatoid arthritis. A meta-analysis of their moderate-term effectiveness
    • Saag KG, Criswell LA, Sems KM, Nettleman MD, Kolluri S. Low-dose corticosteroids in rheumatoid arthritis. A meta-analysis of their moderate-term effectiveness. Arthritis Rheum. 1996;39:1818-25.
    • (1996) Arthritis Rheum , vol.39 , pp. 1818-1825
    • Saag, K.G.1    Criswell, L.A.2    Sems, K.M.3    Nettleman, M.D.4    Kolluri, S.5
  • 8
    • 41849132452 scopus 로고    scopus 로고
    • Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: One-year clinical outcomes (RECONFIRM-2)
    • Tanaka Y, Takeuchi T, Inoue E, Saito K, Sekiguchi N, Sato E, et al. Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: One-year clinical outcomes (RECONFIRM-2). Mod Rheumatol. 2008;18:146-52.
    • (2008) Mod Rheumatol , vol.18 , pp. 146-152
    • Tanaka, Y.1    Takeuchi, T.2    Inoue, E.3    Saito, K.4    Sekiguchi, N.5    Sato, E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.